Data / Medical devices / United States / Corgenix, Inc.
Corgenix, Inc.: FDA-registered device maker in Broomfield, CO, United States, 16 510(k) clearances
Corgenix, Inc. is registered with the FDA (registration 1721937) in Broomfield, CO, United States. It lists 10 device types. The FDA files 16 510(k) clearances under its listings, the newest dated December 15, 2010. Registered through 2026. FDA data exported November 2, 2026.
SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.
- FDA registration number
- 1721937
- FEI number
- 1000117401
- Address
- 11575 Main ST. Suite 400, Broomfield, CO, United States, 80020
- Owner or operator
- CORGENIX, INC. (9001900)
- Roles
- Contract manufacturer, Manufacturer, Manufacturer for export, Repackager or relabeler
- First device listed
- June 4, 2007
- Registered through
- 2026
- Brand names listed
- Anti IL-23 ELISA Test Kit, Anti VEGF-D ELISA Test KIt, Anti-AtherOx IgG Test Kit (IgG anti-oxLDL-B2GPI), Corgenix 11dhTxB2 Test Kit, Corgenix Anti-Beta-2 Glycoprotein IgA Semi-Quantitative Test Kit, Corgenix AspirinWorks Test Kit, Corgenix Collagen Binding Assay, Corgenix HA ELISA Test Kit and more
Devices it lists
| Device | Product code | Class | Role | Source |
|---|---|---|---|---|
| 11-Dehydro Thromboxane B2 Kit, Urinary | OBW | 2 | Contract manufacturer, Manufacturer, Repackager or relabeler | accessdata.fda.gov |
| Control, Plasma, Abnormal | GGC | 2 | Repackager or relabeler | accessdata.fda.gov |
| Galectin-3 In Vitro Diagnostic Assay | OSX | 2 | Manufacturer | accessdata.fda.gov |
| Plasma, Control, Normal | GIZ | 2 | Repackager or relabeler | accessdata.fda.gov |
| Research Use Only/Clinical Chemistry Devices | OTV | N | Manufacturer for export | accessdata.fda.gov |
| Research Use Only/Hematology Devices | OTQ | N | Manufacturer for export | accessdata.fda.gov |
| System, Test, Anticardiolipin Immunological | MID | 2 | Manufacturer, Repackager or relabeler | accessdata.fda.gov |
| System, Test, Systemic Lupus Erythematosus | DHC | 2 | Manufacturer, Repackager or relabeler | accessdata.fda.gov |
| System,Test,Antibodies,B2 - Glycoprotein I (B2 - Gpi) | MSV | 2 | Manufacturer, Repackager or relabeler | accessdata.fda.gov |
| Test, Qualitative And Quantitative Factor Deficiency | GGP | 2 | Manufacturer, Manufacturer for export | accessdata.fda.gov |
510(k) clearances
The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance.
| Decided | 510(k) number | Device | Product code | Decision | Applicant | Source |
|---|---|---|---|---|---|---|
| December 15, 2010 | K100103 | SPECIALTY ASSAYED CONTROL-2 | GGC | Substantially Equivalent | Helena Laboratories | accessdata.fda.gov |
| November 17, 2010 | K093758 | BGM GALECTIN -3 | OSX | Substantially Equivalent | Bg Medicine, Inc. | accessdata.fda.gov |
| April 4, 2008 | K072032 | IGG ANTI-ATHEROX TEST KIT | MSV | Substantially Equivalent | Corgenix, Inc. | accessdata.fda.gov |
| May 29, 2007 | K062025 | ASPIRINWORKS TEST KIT (11-DEHYDRO THROMBOXANE B2), MODEL 12136 | OBW | Substantially Equivalent | Corgenix, Inc. | accessdata.fda.gov |
| April 5, 2004 | K032139 | REAADS VON WILLEBRAND FACTOR ACTIVITY TEST KIT, MODEL 10826 | GGP | Substantially Equivalent | Corgenix, Inc. | accessdata.fda.gov |
| October 14, 2003 | K032868 | REAADS II ANTI-CARDIOLIPIN IGG SEMI-QUANTITATIVE TEST KIT, MODEL 11139 | MID | Substantially Equivalent | Corgenix, Inc. | accessdata.fda.gov |
| July 7, 2003 | K031208 | REAADS IGM ANTI-B2GPI TEST KIT, MODEL 038-001 | MSV | Substantially Equivalent | Corgenix, Inc. | accessdata.fda.gov |
| January 3, 2003 | K024196 | REEADS ANTI-PHOSPHATIDYLSERINE IGG/IGM SEMI-QUANTITATIVE TEST KIT | MID | Substantially Equivalent | Corgenix, Inc. | accessdata.fda.gov |
| January 3, 2003 | K024195 | MODIFICATION TO REAADS ANTI-PHOSPHATIDYLSERINE IGA SEMI-QUANTATIVE TEST KIT | MID | Substantially Equivalent | Corgenix, Inc. | accessdata.fda.gov |
| September 25, 2002 | K022992 | REAADS ANTI-CARDIOLIPIN IGG/IGM SEMI-QUANTITATIVE TEST KIT, MODEL 023-001 | MID | Substantially Equivalent | Corgenix, Inc. | accessdata.fda.gov |
| September 25, 2002 | K022990 | REAADS IGA ANTI-CARDIOLIPIN SEMI-QUANTITATIVE TEST KIT, MODEL 026-001 | MID | Substantially Equivalent | Corgenix, Inc. | accessdata.fda.gov |
| December 22, 1998 | K983914 | REAADS MONOCLONAL FREE PROTEIN S ANTIGEN TEST KIT | GGP | Substantially Equivalent | Corgenix, Inc. | accessdata.fda.gov |
| October 6, 1997 | K972342 | REAADS PROTEIN C ANTIGEN TEST KIT | GGP | Substantially Equivalent | Reaads Medical Products, Inc. | accessdata.fda.gov |
| August 13, 1997 | K972482 | REAADS PROTEIN S ANTIGEN TEST KIT | GGP | Substantially Equivalent | Reaads Medical Products, Inc. | accessdata.fda.gov |
| August 13, 1997 | K972005 | REAADS VON WILLEBRAND FACTOR ANTIGEN TEST KIT | GGP | Substantially Equivalent | Reaads Medical Products, Inc. | accessdata.fda.gov |
| October 7, 1994 | K941737 | SPECIALTY ASSAYED CONTROL-1 | GIZ | Substantially Equivalent | Helena Laboratories | accessdata.fda.gov |
Compare with other makers
- All makers of System,Test,Antibodies,B2 - Glycoprotein I (B2 - Gpi)
- All makers of System, Test, Anticardiolipin Immunological
- All makers of Research Use Only/Clinical Chemistry Devices
- All makers of Test, Qualitative And Quantitative Factor Deficiency
- All makers of System, Test, Systemic Lupus Erythematosus
Updated December 15, 2010. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.